Germany
· Delayed Price · Currency is EUR Dr. Hönle AG Statistics
Total Valuation
Dr. Hönle AG has a market cap or net worth of EUR 58.68 million. The enterprise value is 105.72 million.
| Market Cap | 58.68M |
| Enterprise Value | 105.72M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 41.44 |
| P/OCF Ratio | 16.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.32, with an EV/FCF ratio of 74.66.
| EV / Earnings | -8.15 |
| EV / Sales | 1.10 |
| EV / EBITDA | 18.32 |
| EV / EBIT | 284.20 |
| EV / FCF | 74.66 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.89 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 9.48 |
| Debt / FCF | 38.30 |
| Interest Coverage | 0.15 |
Financial Efficiency
Return on equity (ROE) is -14.73% and return on invested capital (ROIC) is 0.14%.
| Return on Equity (ROE) | -14.73% |
| Return on Assets (ROA) | 0.12% |
| Return on Invested Capital (ROIC) | 0.14% |
| Return on Capital Employed (ROCE) | 0.26% |
| Revenue Per Employee | 164,759 |
| Profits Per Employee | -22,176 |
| Employee Count | 590 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -49.11% |
| 50-Day Moving Average | 8.96 |
| 200-Day Moving Average | 10.48 |
| Relative Strength Index (RSI) | 73.88 |
| Average Volume (20 Days) | 4,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Hönle AG had revenue of EUR 96.38 million and -12.97 million in losses. Loss per share was -2.14.
| Revenue | 96.38M |
| Gross Profit | 59.72M |
| Operating Income | 321,000 |
| Pretax Income | -11.74M |
| Net Income | -12.97M |
| EBITDA | 4.35M |
| EBIT | 321,000 |
| Loss Per Share | -2.14 |
Balance Sheet
The company has 7.47 million in cash and 54.23 million in debt, giving a net cash position of -46.77 million.
| Cash & Cash Equivalents | 7.47M |
| Total Debt | 54.23M |
| Net Cash | -46.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 79.19M |
| Book Value Per Share | 13.02 |
| Working Capital | 27.46M |
Cash Flow
In the last 12 months, operating cash flow was 3.59 million and capital expenditures -2.17 million, giving a free cash flow of 1.42 million.
| Operating Cash Flow | 3.59M |
| Capital Expenditures | -2.17M |
| Free Cash Flow | 1.42M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.96%, with operating and profit margins of 0.33% and -13.46%.
| Gross Margin | 61.96% |
| Operating Margin | 0.33% |
| Pretax Margin | -12.18% |
| Profit Margin | -13.46% |
| EBITDA Margin | 4.52% |
| EBIT Margin | 0.33% |
| FCF Margin | 1.47% |
Dividends & Yields
Dr. Hönle AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -22.11% |
| FCF Yield | 2.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Hönle AG has an Altman Z-Score of 1.89. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | n/a |